Morgan Stanley’s Utah Medical Products UTMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.31M Buy
58,156
+32,251
+124% +$1.84M ﹤0.01% 4383
2025
Q1
$1.45M Sell
25,905
-10,534
-29% -$590K ﹤0.01% 4804
2024
Q4
$2.24M Buy
36,439
+3,843
+12% +$236K ﹤0.01% 4615
2024
Q3
$2.18M Sell
32,596
-3,258
-9% -$218K ﹤0.01% 4589
2024
Q2
$2.4M Sell
35,854
-13,055
-27% -$872K ﹤0.01% 4440
2024
Q1
$3.48M Buy
48,909
+23,915
+96% +$1.7M ﹤0.01% 4199
2023
Q4
$2.11M Buy
24,994
+16,527
+195% +$1.39M ﹤0.01% 4894
2023
Q3
$728K Sell
8,467
-6,941
-45% -$597K ﹤0.01% 4983
2023
Q2
$1.44M Buy
15,408
+256
+2% +$23.9K ﹤0.01% 4618
2023
Q1
$1.44M Buy
15,152
+5,813
+62% +$551K ﹤0.01% 4648
2022
Q4
$939K Sell
9,339
-428
-4% -$43K ﹤0.01% 4908
2022
Q3
$834K Sell
9,767
-93
-0.9% -$7.94K ﹤0.01% 4987
2022
Q2
$847K Buy
9,860
+7,624
+341% +$655K ﹤0.01% 5117
2022
Q1
$201K Buy
2,236
+160
+8% +$14.4K ﹤0.01% 5922
2021
Q4
$209K Buy
2,076
+541
+35% +$54.5K ﹤0.01% 6040
2021
Q3
$142K Sell
1,535
-128
-8% -$11.8K ﹤0.01% 6183
2021
Q2
$141K Buy
1,663
+233
+16% +$19.8K ﹤0.01% 6187
2021
Q1
$124K Sell
1,430
-2,117
-60% -$184K ﹤0.01% 5898
2020
Q4
$299K Buy
3,547
+2,143
+153% +$181K ﹤0.01% 5376
2020
Q3
$113K Sell
1,404
-699
-33% -$56.3K ﹤0.01% 5373
2020
Q2
$187K Buy
2,103
+787
+60% +$70K ﹤0.01% 5102
2020
Q1
$123K Sell
1,316
-4,293
-77% -$401K ﹤0.01% 5098
2019
Q4
$606K Buy
5,609
+3,476
+163% +$376K ﹤0.01% 4825
2019
Q3
$205K Buy
2,133
+799
+60% +$76.8K ﹤0.01% 5119
2019
Q2
$128K Sell
1,334
-149
-10% -$14.3K ﹤0.01% 5207
2019
Q1
$132K Sell
1,483
-11,741
-89% -$1.05M ﹤0.01% 5264
2018
Q4
$1.1M Sell
13,224
-3,076
-19% -$255K ﹤0.01% 4198
2018
Q3
$1.54M Sell
16,300
-3,512
-18% -$331K ﹤0.01% 4205
2018
Q2
$2.18M Sell
19,812
-5,669
-22% -$624K ﹤0.01% 3995
2018
Q1
$2.52M Buy
25,481
+6,421
+34% +$635K ﹤0.01% 3762
2017
Q4
$1.55M Buy
19,060
+1,967
+12% +$160K ﹤0.01% 4244
2017
Q3
$1.26M Sell
17,093
-2,429
-12% -$179K ﹤0.01% 4277
2017
Q2
$1.41M Buy
19,522
+3,112
+19% +$225K ﹤0.01% 4101
2017
Q1
$1.02M Sell
16,410
-4,824
-23% -$300K ﹤0.01% 4366
2016
Q4
$1.54M Buy
21,234
+10,677
+101% +$776K ﹤0.01% 4141
2016
Q3
$632K Buy
10,557
+641
+6% +$38.4K ﹤0.01% 4376
2016
Q2
$625K Buy
9,916
+5,136
+107% +$324K ﹤0.01% 4305
2016
Q1
$299K Sell
4,780
-2,070
-30% -$129K ﹤0.01% 4743
2015
Q4
$401K Sell
6,850
-4,069
-37% -$238K ﹤0.01% 4690
2015
Q3
$588K Buy
10,919
+5,151
+89% +$277K ﹤0.01% 4500
2015
Q2
$344K Buy
5,768
+1,693
+42% +$101K ﹤0.01% 4949
2015
Q1
$244K Sell
4,075
-8,188
-67% -$490K ﹤0.01% 5102
2014
Q4
$736K Sell
12,263
-1,100
-8% -$66K ﹤0.01% 4386
2014
Q3
$651K Buy
13,363
+2,273
+20% +$111K ﹤0.01% 4387
2014
Q2
$570K Buy
11,090
+4,716
+74% +$242K ﹤0.01% 4480
2014
Q1
$369K Buy
6,374
+1,519
+31% +$87.9K ﹤0.01% 4761
2013
Q4
$277K Buy
4,855
+893
+23% +$51K ﹤0.01% 4855
2013
Q3
$236K Buy
3,962
+224
+6% +$13.3K ﹤0.01% 4780
2013
Q2
$203K Buy
+3,738
New +$203K ﹤0.01% 4831